Skip to main content

Vaxart, Inc. (VXRT)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.35
As of

Kresmion compiles this page from VXRT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Vaxart, Inc. (VXRT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-05.

As of . Source: SEC EDGAR filings for VXRT. Method and limitations.

COMPANY DOSSIER

See the full VXRT dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for VXRT on one page. Preview it with sample data, then open it live with a free account.

Preview the VXRT dossier

Active events for VXRT

  • mediumEarnings above estimates

    Q3-2026: Beat consensus by 62.8%, EPS $-0.07 vs $-0.1882 estimate

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 50.4%, EPS $-0.06 vs $-0.1209 estimate

  • mediumEarnings below estimates

    Q4-2025: Missed consensus by 96.1% - EPS $-0.1 vs $-0.051 estimate

  • mediumEarnings above estimates

    Q2-2025: Beat consensus by 20.2% - EPS $-0.07 vs $-0.0877 estimate

  • mediumEarnings above estimates

    Q3-2025: Beat consensus by 40.6% - EPS $-0.04 vs $-0.0673 estimate

FREE, NO ACCOUNT

Every event on VXRT, as it fires

You are seeing 5 of 6 events recorded on VXRT since 2026-05-31.

The five above landed across 4 days. The other 1 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, VXRT

More data on VXRT

VXRT against its peers

VXRT's operating margin of 7.6% ranks in the 79th percentile of 11 Biotechnology sub-industry peers, fiscal periods ending between 2025-01-31 and 2025-12-31.

MetricVXRTPeer medianPercentilen
Revenue FY237M USD1.2M USD9115
Operating margin7.6%-429.5%7911
Net margin6.9%-96.9%7911
Return on equity18.6%-73.5%8921
P / E5.1xn/an/a3
1 year-7.7%-41.4%7723

Peers (24): ANIX, HURA, CBUS, VANI, BETRF, TVGN, ICCC, NRXP, AVXL, PMVP, RLYB, NKTX, VTVT, BDTX, GNLX, PLYX, XGN, UNCY, CHRS, NMRA, TNYA, CUE, ORGO, NBP. Left out: RTSN (no annual filing). Fiscal periods ending between 2025-01-31 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (VXRT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in VXRT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on VXRT in the last 180 days.

Upstream: SEC EDGAR filings for VXRT

Kresmion, "Vaxart, Inc. (VXRT) institutional holdings and SEC filings", data as of 2026-11-15, https://kresmion.com/research/VXRT. Upstream data: SEC EDGAR filings for VXRT.

Link to this data (HTML):

<a href="https://kresmion.com/research/VXRT">Vaxart, Inc. (VXRT) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow VXRT on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to VXRT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the VXRT dossier
Share

The VXRT intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.